Hematopoietic changes induced by a single injection of anti-CD3 monoclonal antibody into normal mice

Stem Cells

Volumn 15, Issue 2, 1997, Pages 154-160

  Schneider, Elke ^a,b   Salaün, Véronique ^a   Amor, Asmâa Ben ^a   Dy, Michel ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

CFU C; GM CSF; Histamine; IL 3

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; OKT 3;

ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; ERYTHROID CELL; FEMALE; GROWTH REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HISTAMINE METABOLISM; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PROTEIN CROSS LINKING;

ANIMALIA; CRICETINAE; MURINAE; TRIXIS;

EID: 0030896505     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150154     Document Type: Article

References (26)

1. Van Wauwe JP, de Mey JR, Goossens JG. OKT3, a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J Immunol 1980;124:2708-2715.
2. Cobbold SP, Martin G, Qin S et al. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986;323:164-167.
3. Vigeral P, Chkoff N, Chatenoud L et al. Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Transplantation 1986;41:730-735.
4. Ortho Multicenter Transplant Study Group. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985;313:337-344.
5. Leo O, Foo M, Sachs DH et al. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 1987;84:1374-1381.
6. Scott DE, Gause WC, Finkelman FD et al. Anti-DC3 antibody induces rapid expression of cytokine genes in vivo. J Immunol 1990;145:2183-2188.
7. Ferran C, Sheehan K, Dy M et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol 1990;20:509-515.
8. Ferran C, Dy M, Sheehan K et al. Inter-mouse strain differences in the in vivo anti-CD3-induced cytokine release. Clin Exp Immunol 1991;86:537-543.
9. Hirsch R, Eckhaus M, Auchinoloss H et al. Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. Immunosuppression of transplantation responses. J Immunol 1988;140:3766-3772.
10. Ellenhorn JDI, Schreiber H, Bluestone JA. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice. J Immunol 1990;144:2840-2846.
11. Matthys P, Dillen C, Proost P et al. Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-gamma or anti-interleukin-6 antibody treatment: protective effect and biphasic changes in blood cytokine levels. Eur J Immunol 1993;23:2209-2216.
12. Ziltener HJ, Clark-Lewis I, McDonald S. Sandwich enzyme immunoassay for murine IL-3. Cytokine 1989;1:56-60.
13. Schrader JW, Moyer C, Ziltener HJ et al. Release of the cytokines colony stimulating factor 1, granulocyte macrophage colony stimulating factor and interleukin 6 by cloned murine vascular smooth muscle cells. J Immunol 1991;146:3799-4005.
14. Lebel B. A high sampling rate automated continuous flow fluorometric technique for the analysis of nanogram levels of histamine in biological samples. Anal Biochem 1983;133:16-22.
15. Hapel AJ, Warren HS, Hume DA. Different colony-stimulating factors are detected by the "interleukin-3"-dependent cell lines FDC-P1 and 32D cl-23. Blood 1984;64:786-791.
16. Hirsch R, Gress RE, Pluznik DH et al. Effects of in vivo administration of anti-CD3 monoclonal antibodies on T cell function in mice. II. In in vivo activation of T cells. J Immunol 1989:142:737-742.
17. Ellenhorn JDI, Hirsch R, Schreiber H et al. In vivo administration of anti-CD3 prevents malignant progressor tumor growth. Science 1988;242:569-572.
18. Schneider E, Ploemacher RE, Nabarra B et al. Mast cells and their committed precursors are not required for interleukin-3-induced histamine synthesis in murine bone marrow: characteristics of histamine-producing cells. Blood 1993;81:1161-1169.
19. Kindler V, Thorens B, Dekossodo S et al. Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3. Proc Natl Acad Sci USA 1985;83:1001-1005.
20. Metcalf D, Begley CG, Johnson GR et al. Effects of purified bacterially-synthesized murine multi-CSF (IL-3) on hemopoiesis in normal adult mice. Blood 1986;687:46-57.
21. Metcalf D, Begley CG, Williamson DJ. Hematopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp Hematol 1987;15:1-9.
22. Lord B, Molineux G, Testa NG et al. The kinetic response of haemopoietic precursor cells, in vivo, to highly purified, recombinant interleukin-3. Lymphokine Res 1986;5:59-72.
23. Broxmeyer HE, Williams DE, Cooper S et al. Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J Clin Invest 1987;79:721-730.
24. Kindler V, Thorens B, Vasalli P. In vivo effect of murine recombinant interleukin 3 on early hematopoietic progenitors. Eur J Immunol 1987;17:1511-1514.
25. Hiruma K, Hirsch R, Patchen M et al. Effects of anti-CD3 monoclonal antibody on engraftment of T-cell-depleted bone marrow allografts in mice: host T-cell suppression, growth factors, and space. Blood 1992;79:3050-3058.
26. Naparstek E, Ohana M, Greenberger JS et al. Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice. Exp Hematol 1993;21:131-137.